Urology
Volume 68, Issue 6 , Pages 1164-1168, December 2006

Incidence of primary urethral carcinoma in the United States

  • Mia A. Swartz

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • Corresponding Author InformationReprint requests: Mia A. Swartz, M.D., M.S., Department of Urology, University of Washington School of Medicine, Box 356510, 1959 Northeast Pacific Street, Seattle, WA 98195.
  • ,
  • Michael P. Porter

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
  • ,
  • Daniel W. Lin

      Affiliations

    • Department of Urology, University of Washington School of Medicine, Seattle, Washington
    • Fred Hutchinson Cancer Research Center, Seattle, Washington
  • ,
  • Noel S. Weiss

      Affiliations

    • Fred Hutchinson Cancer Research Center, Seattle, Washington
    • Department of Epidemiology, University of Washington School of Medicine, Seattle, Washington

Received 7 March 2006; accepted 11 August 2006. published online 04 December 2006.

Abstract 

Objectives

Primary urethral carcinoma is rare, and the demographic correlates of its incidence have not been examined using population-based data.

Methods

The National Cancer Institute Surveillance, Epidemiology, and End Results database was used to identify persons diagnosed with primary urethral carcinoma from 1973 to 2002. During this period, the Surveillance, Epidemiology, and End Results program included population-based tumor registries in nine geographic areas that represented approximately 10% of the U.S. population. The incidence rates were tabulated for the major histologic subtypes according to age, sex, and race.

Results

Primary urethral carcinoma was identified in 1075 men and 540 women, with an annual age-adjusted incidence rate of 4.3 per million and 1.5 per million, respectively. The annual incidence rate increased with age to a peak of 32 per million men and 9.5 per million women in the 75 to 84-year age group. The rate was 5.0 per million and 2.5 per million for African Americans and whites, respectively. The histologic types were transitional cell carcinoma in 888 patients (55%), squamous cell carcinoma in 348 (21.5%), and adenocarcinoma in 265 (16.4%). The incidence of the three primary histologic types varied by race and sex.

Conclusions

In the United States, the incidence of urethral carcinoma is relatively higher in men and African Americans, with a histologic profile differing from that previously described.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by the Ruth L. Kirschstein National Research Service Award.

PII: S0090-4295(06)01961-3

doi:10.1016/j.urology.2006.08.1057

Urology
Volume 68, Issue 6 , Pages 1164-1168, December 2006